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IMM in a Nutshell
• Platform to assess mission medical risk using 
proven risk assessment techniques.
• Platform for exploration of the medical kit trade 
space effects on risk. 
• Gives decision-makers a means to balance 
medical risk with limited resources. 
• Provides engineering teams with quantitative 
medical information to characterize risk.
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This is fundamentally about how the NASA Medical and 
Engineering communities communicate.
Validation Against Real World Observations
• Model validation utilized real world system (RWS) observations 
from International Space Station (ISS) Expedition (Exp) 14 
through 39/40 
• IMM simulation for each expedition
– Assuming ISS med capabilities, crew specific parameters and duration
– Using data obtained from ISS missions and STS missions prior to referent
• Total number, type and outcomes compared to RWS
– RWS LOCL and EVAC set to zero
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Snapshot of results for RWS ISS 
missions: IMM generally over-
predicts by 3-4 medical events as 
indicated by regression intercept 
estimates and slope generally less 
than 1 (considering IMM Condition 
List events only).
Model and External Review
Monte Carlo Simulation: Typically ~100,000 trial simulations
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External Review Panel
ExMC convened an external review panel through 
the GSFC Systems Review Branch 
• Chair: Dr. Bryant Cramer (GSFC – Retired)
• Review Manager: Mr. Neil Martin (GSFC)
• Aerospace Medical: Dr. Jan Stepanek (Mayo Clinic)
• Epidemiologist: Dr. Guohua LI (Columbia University) 
• Chief Engineer /Software: Mr. Steve Scott (GSFC)
• Software: Mr. Robert Schweiss (GSFC)
• Biostatistics/Probability Theory: Dr. Nancy Lindsey (GSFC)
• Software/ Project Management:  Mr. Dick Kauffman (Criterion systems)
• Computational Modeling: Dr. Gary Pradhan (Mayo Clinic)
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External Review Board
IMM External Review
From Nov 2015 to May 2016
• 2 Pre-Meeting Summaries : “Introduction to IMM” and “IMM Validation 
Strategies” 
• Board formally convened three times Dec 2015, Jan 2016, March/April 2016 
External Review Topics
• Model Concepts and Software and code standards (i.e. JPR- 7150.2B 
compliance)
• Input pedigree of incidence and outcomes information (NASA-STD-7009: 
Input Pedigree Credibility Factor)
• Model performance (NASA-STD-7009 Verification, Validation, Sensitivity, 
Operations, Use History) 
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Ensure internal processes for identifying, ranking quality, and including 
medical data with evidence-based rationale are appropriate to capture 
medical risk likelihood, medical information, and outcome uncertainty for 
the model application.
• Presented evidence related to data process and data capture
– A selection of 10 Clinical Findings Forms (CliFFs) summarizing the 
types of data and conditions used to inform IMM simulations
• Atrial Fibrillation
• Burns Secondary to Fire
• Decompression Sickness 
Secondary to EVA
• Dental Abscess
• Headache (Space 
Adaptation)
• Hip-Proximal Femur 
Fracture
• Eye Chemical Burn
• Stroke
• Sepsis
• Urinary Retention (Space 
Adaptation)
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Input Pedigree
Summary Review Comments
Board identified strengths: 
• The concept of the IMM is scientifically sound and it works.
• The IMM represents a necessary, comprehensive approach to identifying medical 
and environmental risks facing astronauts in long duration missions.
• Because it integrates with the Exploration Probabilistic Risk Assessment 
(ExPRAT), the IMM has become an excellent tool through which engineers and 
physicians can better communicate with each other by speaking a common risk 
assessment language.
• The validation approach is sound and the use of actual space medical data is 
logical and compelling.
• IMM statistical methods for processing and analyzing the input data, performing 
simulations, and generating and presenting quantitative outputs are scientifically 
sound.
• The IMM validation approach is sound and the match between the IMM and the real 
world system is good.
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Summary Review Comments cont.
Board identified issues:
• Need for stronger software engineering involvement particularly in terms of quality 
assurance.
• Accuracy concerns regarding the CliFFs; the Board found a number of errors 
necessitating a robust review of all remaining CliFFs.
• Need for a sustainable approach to augment, peer review, and maintain the CliFFs.
• Organizational issues:
– Physical separation of Project Management from Development Team presents a challenge.
– Evolutionary path for IMM insufficiently defined.
– Need for a well-developed Operations Concept.
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RFA Summary
• Total of 28 RFAs and 6 advisories submitted
• Project combined 8 of the RFAs for consolidated 
responses 
– New total : 24 RFAs
• RFA closure summary
– All submitted for closure as of 11/15/2016
• 23 – Evidence or plan to secure evidence supplied as a 
response
• 1 – Element and project decision not to pursue a response at 
this time
– Closure acceptance received 12/2016
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Summary of Significant RFA Closure Activities
• Code modifications were performed to reduce run times by 70%. 
• Adjustments to reviewed condition information
– Minor typographical updates to DCS and Stroke CLIFF. 
– Updated data after addressing board suggestions and source data from the primary references.
• Dental Abscess CLIFF – reevaluation of source data categorization of medical condition.
• Space Adaptation headache leading to evacuation reduced from 1.5% max to 0% max.
• Eye Chemical Burn – updated rationale.
• Sepsis – updated rationale.
• Developed survey document guidelines for improved configuration management of 
clinical data identification.
• Performed a calibration of CHI using the RWS and iMED data information  (Accepted for 
Closure RFA 3.02).
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IMM Project Planned Pre-Delivery Activities
• Updated NASA-7009 Credibility Thresholds per accepted RFA plan 
(12/1/2016 – 3/7/2017)
• Complete STS RWS validation activity (12/1/2016 – 6/1/2017)
• Complete iMED 6.5  (12/5/2016 – 2/10/2017)
• Add RWS data to iMED 6.5 (3/31/2107 – 4/21/2017)
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Conclusions
• IMM is a tool intended to help mission planners make 
decisions regarding medical risk and supplies.
• It is intended to pull in data and experience to provide the 
best current information to inform medical resource 
planning.
• Outcomes of the IMM 4.0 review
– Definite need for the model of this type  - validation testing illustrates its utility
– Concerns expressed that the medical condition information requires further 
review
• Forward work plan toward transition to customer baselined
– Final negotiation of ConOps plan with CHS
– RWS validation for STS and RWS data integrated into iMED
– Completion planned NLT 5/30/2017
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